Rationale and design of the Myocardial Ischemia Reduction With Aggressive Cholesterol lowering (MIRACL) Study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.
作者信息
Ghali J K
出版信息
Am J Cardiol. 1998 Sep 1;82(5):703.
PMID:9732912
Abstract
摘要
相似文献
1
Rationale and design of the Myocardial Ischemia Reduction With Aggressive Cholesterol lowering (MIRACL) Study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.积极降低胆固醇减少心肌缺血（MIRACL）研究的原理与设计，该研究评估阿托伐他汀在不稳定型心绞痛和非Q波急性心肌梗死中的作用。
Am J Cardiol. 1998 Sep 1;82(5):703.
2
Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.积极降低胆固醇减少心肌缺血（MIRACL）研究的原理与设计，该研究评估阿托伐他汀在不稳定型心绞痛和非Q波急性心肌梗死中的作用。
Am J Cardiol. 1998 Mar 1;81(5):578-81. doi: 10.1016/s0002-9149(97)00963-6.
3
Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy.阿托伐他汀对不稳定型心绞痛或非Q波心肌梗死患者中风的影响：积极降低胆固醇减少心肌缺血（MIRACL）研究的一项子研究。
Circulation. 2002 Sep 24;106(13):1690-5. doi: 10.1161/01.cir.0000031568.40630.1c.
4
[Meeting report. "MIRACL" study of "Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering"].[会议报告。“积极降低胆固醇减少心肌缺血”（MIRACL）研究]
Rev Med Liege. 2000 Dec;55(12):1064-6.
5
Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study.阿托伐他汀对急性冠状动脉综合征后复发性心血管事件风险的影响，该急性冠状动脉综合征与强化降胆固醇治疗降低心肌缺血（MIRACL）研究中高可溶性CD40配体相关。
Circulation. 2004 Jul 27;110(4):386-91. doi: 10.1161/01.CIR.0000136588.62638.5E. Epub 2004 Jul 19.
6
Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction.阿托伐他汀（80毫克）对不稳定型心绞痛和非Q波急性心肌梗死的抗炎作用。
Am J Cardiol. 2003 Aug 1;92(3):298-301. doi: 10.1016/s0002-9149(03)00630-1.
7
Intensive versus moderate lipid lowering with statins in acute coronary syndromes.他汀类药物强化降脂与中度降脂治疗急性冠状动脉综合征的比较。
Curr Atheroscler Rep. 2005 Mar;7(2):85-6.
8
What is the role of intensive cholesterol lowering in the treatment of acute coronary syndromes?
Am J Cardiol. 2001 Oct 11;88(7B):7J-16J. doi: 10.1016/s0002-9149(01)01921-x.
9
[Statins and unstable angina: MIRACL].
Ann Endocrinol (Paris). 2001 Feb;62(1 Pt 2):145-8.
10
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.阿托伐他汀对急性冠状动脉综合征早期再发缺血事件的影响：MIRACL研究：一项随机对照试验
JAMA. 2001 Apr 4;285(13):1711-8. doi: 10.1001/jama.285.13.1711.
Zotero 插件